The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...
In August, the agency announced a new program called FDA PreCheck, 2 which is designed to increase regulatory predictability ...
Hosted on MSN
Lantheus Holdings, Inc. (LNTH) Announces FDA Approval of its New Drug Application for F 18 PSMA Imaging Agent
With a price-to-earnings multiple under 15x and its relative strength index below 40, Lantheus Holdings, Inc. (NASDAQ:LNTH) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now.
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, ...
LEO Pharma continues global rollout of Anzupgo® (delgocitinib) cream with submission of New Drug Application in China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback